This study focuses on cardiovascular effects, particularly myocarditis and pericarditis events, after BNT162b2 mRNA COVID-19 vaccine injection in Thai adolescents. This prospective cohort study enrolled students from two schools aged 13–18 years who received the second dose of the BNT162b2 mRNA COVID-19 vaccine. Data including demographics, symptoms, vital signs, ECG, echocardiography and cardiac enzymes were… Continue reading Cardiovascular Effects of the BNT162b2 mRNA COVID-19 Vaccine in Adolescents
Tag: Vaccines
Covid-19: Regulators warn that rare Guillain-Barré cases may link to J&J and AstraZeneca vaccines
Rapid Response:Autoimmune damage to the nerves following Covid vaccines: EMA issued warning to patients and healthcare professionalsDear EditorEMA recently investigated the cases of Guillain-Barre syndrome (GBS) following Covid vaccine AstraZeneca (AZ) and have issued a warning to raise awareness of healthcare professionals and the public about GBS cases following Covid vaccinations and recommended revising the… Continue reading Covid-19: Regulators warn that rare Guillain-Barré cases may link to J&J and AstraZeneca vaccines
Immune boosting by B.1.1.529 (Omicron) depends on previous SARS-CoV-2 exposure
Importance of infection historyA long-term study of healthcare workers in the United Kingdom has allowed their history of infection and vaccination to be traced precisely. Reynolds et al. found some unexpected immune-damping effects caused by infection with a heterologous variant to the latest wave of infection by the Omicron/Pango lineage B.1.1.529. The authors found that… Continue reading Immune boosting by B.1.1.529 (Omicron) depends on previous SARS-CoV-2 exposure
Risk of covid-19 related deaths for SARS-CoV-2 omicron (B.1.1.529) compared with delta (B.1.617.2): retrospective cohort study
Objective To assess the risk of covid-19 death after infection with omicron BA.1 compared with delta (B.1.617.2).Design Retrospective cohort study.Setting England, United Kingdom, from 1 December 2021 to 30 December 2021.Participants 1 035 149 people aged 18-100 years who tested positive for SARS-CoV-2 under the national surveillance programme and had an infection identified as omicron BA.1 or… Continue reading Risk of covid-19 related deaths for SARS-CoV-2 omicron (B.1.1.529) compared with delta (B.1.617.2): retrospective cohort study
Update: COVID-19 Vaccine Candidates and Abortion-Derived Cell Lines
Accurate information about the development and production of COVID-19 vaccines is essential, especially because many proposed candidates use newer molecular technologies for production of a viral vaccine. One concern regarding the ethical assessment of viral vaccine candidates is the potential use of abortion-derived cell lines in the development, production or testing of a vaccine. This… Continue reading Update: COVID-19 Vaccine Candidates and Abortion-Derived Cell Lines
Acute Disseminated Encephalomyelitis After SARS-CoV-2 Vaccination
BACKGROUND: Acute disseminated encephalomyelitis (ADEM) is a disorder of the central nervous system which has been associated with preceding infection as well as vaccinations. We present a case of a 61-year-old woman with ADEM after receiving her initial vaccination for the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). This case highlights management of this acute… Continue reading Acute Disseminated Encephalomyelitis After SARS-CoV-2 Vaccination
Imperial fantasy of 20 million lives saved
Imperial College has produced a new fantasy number to test people’s gullibility. This time they are claiming that 19.8 million lives have been saved by vaccination.Imperial College now have a global reputation for making provable wrong claims based on modelling and they appear to want to bolster that reputation. Previous harm caused by Imperial include… Continue reading Imperial fantasy of 20 million lives saved
Simultaneous Occurrence of Immune-Mediated Thrombocytopenia and Myocarditis After mRNA-1273 COVID-19 Vaccination: A Case Report
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Naturally Acquired Immunity versus Vaccine-induced Immunity, Reinfections versus Breakthrough Infections: A Retrospective Cohort Study
BackgroundWaning of protection against infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) conferred by 2 doses of the BNT162b2 vaccine begins shortly after inoculation and becomes substantial within 4 months. With that, the impact of prior infection on incident SARS-CoV-2 reinfection is unclear. Therefore, we examined the long-term protection of naturally acquired immunity (protection… Continue reading Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Naturally Acquired Immunity versus Vaccine-induced Immunity, Reinfections versus Breakthrough Infections: A Retrospective Cohort Study